22-23787171-T-C

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2

The NM_003073.5(SMARCB1):​c.2T>C​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

SMARCB1
NM_003073.5 start_lost

Scores

4
6
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.53
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SMARCB1NM_003073.5 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/9 ENST00000644036.2 NP_003064.2 Q12824-1
SMARCB1NM_001362877.2 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/9 NP_001349806.1
SMARCB1NM_001317946.2 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/9 NP_001304875.1 G5E975Q9H836
SMARCB1NM_001007468.3 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/9 NP_001007469.1 Q12824-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SMARCB1ENST00000644036.2 linkuse as main transcriptc.2T>C p.Met1? start_lost 1/9 NM_003073.5 ENSP00000494049.2 Q12824-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2024The p.M1? variant (also known as c.2T>C) is located in coding exon 1 of the SMARCB1 gene and results from a T to C substitution at nucleotide position 2. This alters the methionine residue at the initiation codon (ATG). Variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame; however, there is an in-frame methionine 1 amino acid from the initiation site, which may result in N-terminal truncation of unknown functional significance. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Uncertain
0.11
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.27
.;T;T;.;.;T
Eigen
Benign
-0.045
Eigen_PC
Benign
0.0083
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.90
.;.;.;.;D;D
M_CAP
Pathogenic
0.97
D
MetaRNN
Pathogenic
0.97
D;D;D;D;D;D
MetaSVM
Uncertain
0.65
D
PROVEAN
Benign
-0.24
N;.;N;N;N;N
REVEL
Uncertain
0.59
Sift
Pathogenic
0.0
D;.;D;D;D;D
Sift4G
Uncertain
0.012
D;.;D;D;D;D
Polyphen
0.0, 0.0010, 0.72
.;B;B;.;.;P
Vest4
0.76
MutPred
0.83
Gain of glycosylation at M1 (P = 0.0054);Gain of glycosylation at M1 (P = 0.0054);Gain of glycosylation at M1 (P = 0.0054);Gain of glycosylation at M1 (P = 0.0054);Gain of glycosylation at M1 (P = 0.0054);Gain of glycosylation at M1 (P = 0.0054);
MVP
0.84
ClinPred
1.0
D
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.89
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr22-24129358; API